References
- American Diabetes Association. Economic costs of diabetes in the U.S. in 2012. Diabetes Care 2013;36:1033-46
- International Diabetes Federation. IDF Diabetes Atlas. Brussels, Belgium: IDA; 2015
- American Diabetes Association. Standards of medical care in diabetes–2015. Diabetes Care 2015;38(Suppl1):S1-S93
- Banerji MA, Dunn JD. Impact of glycemic control on healthcare resource utilization and costs of type 2 diabetes: current and future pharmacologic approaches to improving outcomes. Am Health Drug Benefits 2013;6:382-92
- Gilmer TP, O’Connor PJ, Rush WA, et al. Predictors of health care costs in adults with diabetes. Diabetes Care 2005;28:59-64
- McBrien KA, Manns BJ, Chui B, et al. Health care costs in people with diabetes and their association with glycemic control and kidney function. Diabetes Care 2013;36:1172-80
- Wagner EH, Sandhu N, Newton KM, et al. Effect of improved glycemic control on health care costs and utilization. JAMA 2001;285:182-9
- Ceriello A. The glucose triad and its role in comprehensive glycaemic control: current status, future management. Int J Clin Pract 2010;64:1705-11
- Monnier L, Colette C, Dunseath GJ, et al. The loss of postprandial glycemic control precedes stepwise deterioration of fasting with worsening diabetes. Diabetes Care 2007;30:263-9
- Monnier L, Lapinski H, Colette C. Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients: variations with increasing levels of HbA(1c). Diabetes Care 2003;26:881-5
- Handelsman Y, Bloomgarden ZT, Grunberger G, et al. American association of clinical endocrinologists and american college of endocrinology - clinical practice guidelines for developing a diabetes mellitus comprehensive care plan - 2015. Endocr Pract 2015;21(Suppl1):1-87
- International Diabetes Federation Guideline Development G. Guideline for management of postmeal glucose in diabetes. Diabetes Res Clin Pract 2014;103:256-68
- Sandberg A, Buchs S, Hadi M, et al. Improvements in health-related quality of life associated with increased control of postprandial glucose levels in diabetes. Value Health 2016;19:A678
- Aryangat AV, Gerich JE. Type 2 diabetes: postprandial hyperglycemia and increased cardiovascular risk. Vasc Health Risk Manag 2010;6:145-55
- Cavalot F, Pagliarino A, Valle M, et al. Postprandial blood glucose predicts cardiovascular events and all-cause mortality in type 2 diabetes in a 14-year follow-up: lessons from the San Luigi Gonzaga Diabetes Study. Diabetes Care 2011;34:2237-43
- Cavalot F, Petrelli A, Traversa M, et al. Postprandial blood glucose is a stronger predictor of cardiovascular events than fasting blood glucose in type 2 diabetes mellitus, particularly in women: lessons from the San Luigi Gonzaga Diabetes Study. J Clin Endocrinol Metab 2006;91:813-19
- Ceriello A. Cardiovascular effects of acute hyperglycaemia: pathophysiological underpinnings. Diab Vasc Dis Res 2008;5:260-8
- Nathan DM, Group DER. The diabetes control and complications trial/epidemiology of diabetes interventions and complications study at 30 years: overview. Diabetes Care 2014;37:9-16
- Standl E, Schnell O, Ceriello A. Postprandial hyperglycemia and glycemic variability: should we care? Diabetes Care 2011;34(Suppl2):S120-S7
- Stratton IM, Adler AI, Neil HA, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 2000;321:405-12
- Brod M, Nikolajsen A, Weatherall J, et al. The economic burden of post-prandial hyperglycemia (PPH) among people with type 1 and type 2 diabetes in three countries. Diabetes Ther 2016;7:75-90
- Brod M, Nikolajsen A, Weatherall J, et al. Understanding post-prandial hyperglycemia in patients with type 1 and type 2 diabetes: a web-based survey in Germany, the UK, and USA. Diabetes Ther 2016;7:335-48
- Hilbe JM. Modeling count data. New York (NY): Cambridge University Press; 2014
- Long JS, Freese J. Regression models for categorical dependent variables using Stata, 3rd edition. College Station (TX): Stata Press Publication, StataCorp LP; 2014
- Menzin J, Korn JR, Cohen J, et al. Relationship between glycemic control and diabetes-related hospital costs in patients with type 1 or type 2 diabetes mellitus. J Manag Care Pharm 2010;16:264-75
- Brindisi MC, Hahn J, Chiasson JL, et al. Under-utilization of capillary glucose monitoring by type 2 diabetic patients. Diabetes Res Clin Pract 2007;75:123-5
- Duran A, Martin P, Runkle I, et al. Benefits of self-monitoring blood glucose in the management of new-onset Type 2 diabetes mellitus: the St Carlos Study, a prospective randomized clinic-based interventional study with parallel groups. J Diabetes 2010;2:203-11
- Inzucchi SE, Bergenstal RM, Buse JB, et al. Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2015;38:140-9